Nancy Miller-Rich

Nancy Miller-Rich is a declared insider at 2 companies (board member); the most frequent names are Intercept Pharmaceuticals, Inc. and Aldeyra Therapeutics, Inc. The record holds 5 filings, for trades running from 3 May 2021 to 8 November 2023.

The open-market record is one-sided, with 1 purchase worth €4,386 and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 3 share grants. So far in 2024, the count stands at 1 purchase and no sales.

Most recently, on 21 October 2024, the filings show an open-market purchase worth €4,386 in Aldeyra Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.